In this study, we used a classical optic nerve injury model to address the function of the sphingosine 1-phosphate (S1P)-S1P receptor (S1PR) axis in retinal ganglion cell (RGC) death and axonal growth. After lesion, the expression of S1PR1 was generally reduced in axotomized RGCs but persisted in aRGCs, a subpopulation of injury-resistant RGCs. Silencing S1PR1 with an adeno-associated virus serotype 2 (AAV2) containing a shRNA specific to S1PR1 (AAV2.shRNA-S1PR1) exacerbated the loss of RGCs induced by optic nerve crush; the rate of RGC survival was decreased by more than 24% in retinae infected with AAV2.shRNA-S1PR1 compared with AAV2.shRNA-scrambled or AAV2.GFP control treatments. In the superior and temporal regions of the retina, cell death rose by more than~35% and~50%, respectively, in comparison with control groups. In the optic nerve, S1PR1 silencing markedly reduced axonal sprouting after the lesion relative to control animals. Early after optic nerve crush, 67% of aRGCs stained for osteopontin were lost in retinae infected with AAV2.shRNA-S1PR1, whereas the number of intrinsically photosensitive RGCs expressing melanopsin, another injuryresistant RGC type, was not affected. Moreover, retinal infection with AAV2.shRNA-S1PR1 down-regulated mammalian target of rapamycin pathway activation in aRGCs. Together, our results reveal that S1PR1 contributes to survival and growth mechanisms in injured RGCs by regulating the mammalian target of rapamycin pathway. Keywords: axonal regeneration, injury-resistant RGCs, neuronal survival, optic nerve crush injury, retinal ganglion cells, sphingosine 1-phosphate. Despite the major progresses achieved in this field over the last 20 years, the mechanisms of RGC death are not entirely clear; although the majority of RGCs are lost after complete optic nerve lesion in rodents, a small portion of them stays alive for an extended period of time (Villegas-Perez et al. 1993; Berkelaar et al. 1994). Strikingly, recent studies revealed the identity of some RGC subtypes that are naturally resistant to optic nerve injury such as aRGCs expressing a high level of the osteopontin protein (OPN), and intrinsically photosensitive RGCs (ipRGCs) that selectively express melanopsin photopigment (Li et al. 2006;Duan et al. 2015). However, the molecular mechanisms controlling ipRGC and aRGC survival are not well understood (Duan et al. 2015). The elucidation of the molecular Received February 2, 2016; revised manuscript received June 11, 2016; accepted June 12, 2016.Address correspondence and reprint requests to Vincent Pernet, PhD, CUO-Recherche, Universit e Laval, Centre de recherche du CHU de Qu ebec-Pavillon CHUL, 2705, Boul Laurier-Local P-09825, Quebec City, QC G1V 4G2, Canada. E-mail: vincent.pernet.1@ulaval.caAbbreviations used: AAV, adeno-associated virus; AKT, protein kinase B; CNS, central nervous system; CNTF, ciliary neurotrophic factor; CREB, cAMP response element-binding protein; CTb, cholera toxin b coupled to Alexa594; ERK1/2, extracellular signal-regulated kinases ½;...